Foxby Corp. (FXX) Files For Delisting From AMEX
Tweet Send to a Friend
Foxby Corp. (AMEX: FXX) has filed a Form 25 with the Securities and Exchange Commission ("SEC") to withdraw the listing of its common stock from the American Stock Exchange ("AMEX") to become effective on October 24, 2008.
The Fund expects that delisting will allow management to focus its resources on pursuing the Fund's investment objectives and position the Fund to enhance long term stockholder value. The Fund will continue to maintain its investment company registration and update its stockholders with financial information as required.
Following the effectiveness of the Form 25 filing, the Fund anticipates that its common stock will be quoted over-the-counter on the OTC Bulletin Board ("OTCBB") or Pink OTC Markets Inc. ("Pink Sheets") to the extent market makers commit to make a market in the Fund's shares, although the Fund can provide no assurance that trading in the stock will continue. [SM]
The Fund expects that delisting will allow management to focus its resources on pursuing the Fund's investment objectives and position the Fund to enhance long term stockholder value. The Fund will continue to maintain its investment company registration and update its stockholders with financial information as required.
Following the effectiveness of the Form 25 filing, the Fund anticipates that its common stock will be quoted over-the-counter on the OTC Bulletin Board ("OTCBB") or Pink OTC Markets Inc. ("Pink Sheets") to the extent market makers commit to make a market in the Fund's shares, although the Fund can provide no assurance that trading in the stock will continue. [SM]
You May Also Be Interested In
- Gleacher & Co. (GLCH) Reports Election of Five for Board Members
- St. Jude Medical (STJ) Issues Encouraging Update for EnligHTN™ Multi-Electrode Renal Denervation System Following One Year
- Cardiovascular Systems (CSII) ORBIT II Trial Met Endpoints
Create E-mail Alert Related Categories
Corporate NewsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

